Genetic test maker Sequenom Inc. said Monday it will collaborate with Illumina on a new test that detects fetal abnormalities that can lead to Down syndrome.
Popular Posts:
- Pfizer, Genentech tout arthritis drug test data
- U.S. to develop chip that tests if a drug is toxic
- US House Tones Down Healthcare Debate After Shooting
- FDA cracks down on J&J sites linked to recalls
- Affymetrix releases new tool to test rice genes